
1. cell mol neurobiol. 2011 nov;31(8):1229-43. doi: 10.1007/s10571-011-9725-y. epub 
2011 jun 17.

adenoviral astrocyte-specific expression bdnf striata mice
transgenic huntington's disease delays onset motor phenotype.

arregui l(1), benítez ja, razgado lf, vergara p, segovia j.

author information: 
(1)departamento de fisiología, biofísica neurociencias, centro de investigación
y de estudios avanzados del ipn, av. instituto politécnico nacional # 2508, 07360
mexico, df, mexico.

huntington's disease (hd) neurodegenerative disorder characterized motor,
cognitive, psychiatric symptoms. characteristic structural feature
of disease neurodegeneration accompanied gliosis striatum. bdnf
has proposed protect striatal neurons degeneration, an
important survival factor neurons development adulthood.
considering extensive gliosis survival effects bdnf, we
constructed adenovirus express bdnf cdna astrocyte cells using a
promoter glial fibrillary acidic protein gene. cells stably transfected in
vitro bdnf cdna driven promoter expressed bdnf responded to
external stimuli increasing bdnf production. vector applied the
striata mice transgenic hd, long-term expression transgene was
observed, associated delay onset motor phenotype r6/2 hd 
transgenic mice. present data indicate striatal expression bdnf
is potential adjuvant treatment hd.

doi: 10.1007/s10571-011-9725-y 
pmid: 21681558  [indexed medline]

